SCHEMBL19633240

SCHEMBL19633240

CCC(C)Oc1cc(OC)c(Cl)c(N(C(=O)OC(C)(C)C)C(=O)N(C)c2cc(Cl)ncn2)c1Cl

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 11/20 0.33
▸ FGFR3 P22607 8/20 0.33
▸ FGFR4 P22455 8/20 0.33
▸ FGFR2 P21802 3/20 0.33
▸ JAK2 O60674 2/20 0.33
▸ ABL1 P00519 2/20 0.33
▸ INSR P06213 2/20 0.33
▸ LCK P06239 2/20 0.33
▸ FYN P06241 2/20 0.33
▸ YES1 P07947 2/20 0.33
▸ LYN P07948 2/20 0.33
▸ RET P07949 2/20 0.33
▸ MET P08581 2/20 0.33
▸ ROS1 P08922 2/20 0.33
▸ KIT P10721 2/20 0.33
▸ SRC P12931 2/20 0.33
▸ BRAF P15056 2/20 0.33
▸ PDGFRA P16234 2/20 0.33
▸ FLT1 P17948 2/20 0.33
▸ TYK2 P29597 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19633217 0.91 FGFR4 (0.34) FGFR1FGFR3FGFR4FGFR2JAK2
SCHEMBL30745811 0.90 FGFR4 (0.37) FGFR1FGFR3FGFR4FGFR2JAK2
SCHEMBL16659621 0.90 FGFR4 (0.37) FGFR1FGFR3FGFR4FGFR2JAK2
SCHEMBL18138247 0.84 FGFR4 (0.35) FGFR1FGFR3FGFR4FGFR2JAK2
SCHEMBL23889743 0.83 FGFR4 (0.37) FGFR1FGFR3FGFR4FGFR2JAK2
SCHEMBL23665610 0.81 FGFR4 (0.38) FGFR1FGFR3FGFR4FGFR2JAK2
SCHEMBL18138353 0.80 FGFR4 (0.34) FGFR1FGFR3FGFR4FGFR2JAK2
SCHEMBL17728857 0.78 FGFR4 (0.43) FGFR1FGFR3FGFR4FGFR2JAK2
SCHEMBL20836819 0.77 FGFR4 (0.39) FGFR1FGFR3FGFR4FGFR2JAK2
SCHEMBL28609741 0.77 FGFR1 (0.33) FGFR1FGFR3FGFR4FGFR2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017198221-A1 PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME AND USE THEREOF IN MEDICINE 浙江海正药业股份有限公司 2017-11-23 — — WO disclosed
Send feedback